Liquet Medical, Inc.
Liquet Medical is a forward-thinking medical device company dedicated to developing next-generation solutions for blood clots and other vascular conditions. Their mission is to transform vascular disease treatment through localized drug delivery, emphasizing patient outcomes and healthcare sustainability. They focus on innovative, patient-centric medical technologies, including the Versus Catheter, which offers dual-tip infusion, real-time pressure monitoring, and flow-directed placement.
Industries
Nr. of Employees
small (1-50)
Products
Dual-tip pulmonary artery infusion catheter with integrated pressure monitoring
An interventional catheter device designed for localized pulmonary artery drug delivery with dual infusion tips to treat both lungs from a single access, integrated real-time pulmonary artery pressure sensing, and placement via flow-directed balloon or standard guidewire technique.
Dual-tip pulmonary artery infusion catheter with integrated pressure monitoring
An interventional catheter device designed for localized pulmonary artery drug delivery with dual infusion tips to treat both lungs from a single access, integrated real-time pulmonary artery pressure sensing, and placement via flow-directed balloon or standard guidewire technique.
Services
Collaborative pilot study to evaluate the use of integrated real-time pulmonary artery pressure monitoring during catheter-directed therapy.
Collaborative pilot study to evaluate the use of integrated real-time pulmonary artery pressure monitoring during catheter-directed therapy.
Expertise Areas
- Catheter-based vascular device design
- Hemodynamic monitoring and data-driven therapy
- Clinical trial initiation and pilot studies
- Regulatory strategy and 510(k) submissions
Key Technologies
- Dual-tip telescoping catheter architecture
- Integrated intravascular pressure sensing
- Flow-directed balloon catheter navigation
- Catheter-directed drug infusion systems
News & Updates
Evaluating Real-Time Hemodynamic Monitoring
Liquet Medical received FDA 510(k) clearance for its Versus™ Catheter, enabling personalized treatment of blood clots in the lungs using real-time pulmonary artery pressure measurements.
Gabriele G. Niederauer, PhD, appointed as Chair of the Board to support regulatory clearance and product performance demonstration.
VIPC’s Virginia Venture Partners invested in Liquet Medical to support the transformation of vascular disease treatment.
Liquet Medical received $368,797 non-dilutive funding from Virginia Catalyst.
Liquet Medical received a grant from the Commonwealth Commercialization Fund.
Evaluating Real-Time Hemodynamic Monitoring
Liquet Medical received FDA 510(k) clearance for its Versus™ Catheter, enabling personalized treatment of blood clots in the lungs using real-time pulmonary artery pressure measurements.
Gabriele G. Niederauer, PhD, appointed as Chair of the Board to support regulatory clearance and product performance demonstration.
VIPC’s Virginia Venture Partners invested in Liquet Medical to support the transformation of vascular disease treatment.
Liquet Medical received $368,797 non-dilutive funding from Virginia Catalyst.
Liquet Medical received a grant from the Commonwealth Commercialization Fund.